tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market

Cytokinetics (CYTK) Income Statement

Compare
1,208 Followers

Cytokinetics Income Statement

Last quarter (Q3 2025), Cytokinetics's total revenue was $1.94M, an increase of 318.14% from the same quarter last year. In Q3, Cytokinetics's net income was $-306.18M. See Cytokinetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.47M$ 7.53M$ 94.59M$ 70.43M$ 55.83M
Gross Profit
$ -320.93M$ -322.59M$ -146.22M$ -89.51M$ -41.12M
Operating Expenses
$ 215.31M$ 173.61M$ 177.98M$ 96.80M$ 52.82M
Depreciation and Amortization
$ 9.53M$ 11.89M$ 8.40M$ 9.64M$ 1.83M
EBITDA
$ -493.48M$ -456.68M$ -329.40M$ -176.34M$ -86.78M
Operating Income
$ -536.25M$ -496.20M$ -324.20M$ -186.31M$ -93.94M
Other Income/Expenses
$ -53.28M$ -30.04M$ -64.75M$ -29.00M$ -33.35M
Pretax Income
$ -589.53M$ -526.24M$ -388.95M$ -215.31M$ -127.29M
Net Income
$ -589.53M$ -526.24M$ -388.95M$ -215.31M$ -127.29M
Per Share Metrics
Basic EPS
$ -5.26$ -5.45$ -4.33$ -2.80$ -1.97
Diluted EPS
$ -5.26$ -5.45$ -4.33$ -2.80$ -1.97
Weighted Average Shares Outstanding
111.98M 96.52M 89.83M 76.89M 64.52M
Weighted Average Shares Outstanding (Diluted)
111.98M 96.52M 89.83M 76.89M 64.52M
Currency in USD

Cytokinetics Earnings and Revenue History